Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography. Issue 190 (June 2020)

• Record Type: Journal Article
• Authors: Rotzinger, D.C.; Beigelman-Aubry, C.; von Garnier, C.; Qanadli, S.D.
• Is Part Of: Thrombosis research. Issue 190(2020)
• Page Start: 58
• Page End: 59
• Publication Date: 2020-06
• Subjects: COVID-19: coronavirus disease 2019 -- lung infection -- pulmonary thromboembolism -- SARS-CoV-2: severe acute respiratory syndrome coronavirus 2 -- computed tomography pulmonary angiography; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2020.04.011
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: Objective: To raise awareness for possible benefits of examining known COVID-19 patients presenting sudden clinical worsening with CT pulmonary angiography instead of standard non-contrast chest CT. Highlights: Patients having COVID-19 pneumonia are at risk of coagulopathy and pulmonary embolism In the absence of contraindications, patients admitted for COVID-19 should receive prophylactic low molecular weight heparin Elevated D-dimer levels on admission or sudden clinical deterioration should raise suspicion of pulmonary embolism Selected patients may benefit from CT pulmonary angiography to confirm pulmonary embolism and initiate appropriate therapy